In diet-induced obese mice, treatment with CTLA4-Ig reduced body weight, improved insulin resistance and reduced adipose tissue inflammation by a mechanism involving adiponectin upregulation, M1 to M2 macrophage polarization, Treg stimulation, and TGF-β signaling (95, 96). This evidence concerns the gene TGFB1 and Insulin resistance.